Why it runs its programme backwards, why killing it makes it worse, and why the cure is to send it home
Every living cell carries an address. Not a metaphor — a precise coordinate within the {2,3,5,π} lattice that governs all biology. At that address the cell's whole chemistry sits in the smooth {2,3,5} zone: its enzyme kinetics, its protein folding, the fidelity with which it copies itself, all calibrated to the body's own nodes. The address is held in place by the suppressor-gene network — p53, BRCA1/2, APC, RB1, PTEN — which is nothing other than the cell's own instantiation of the conservation law dΣΤ=0: a self-correction machinery that pulls the cell back to its lattice node whenever it drifts. Conventional oncology sees a stochastic shower of mutations; the Force of Time sees one deterministic event — the loss of the address itself.
And the address is written where you would least expect it. The 98% of the human genome that science long dismissed as junk is, in the Force of Time, the Τ-address space — the coordinate system that locates a cell within the body's lattice, the part of the DNA that says not what protein but where in the field. The protein-coding 2% builds the machine; the silent 98% tells the machine where it stands. Cancer is damage to the standing-where, which is why a cancer cell can keep its proteins and still forget entirely what it is.
Here is the heart of it. Seven — the smallest prime outside {2,3,5} — does not sit on the lattice at all. On the Earth register the lattice is {2,3,5,π} and nothing else; there is no prime-7 node for a cell to move onto, because a prime-7 position is not a node but a point in the empty space between the nodes. So cancer is not a cell climbing onto a new address. It is a cell whose true {2,3,5,π} value has drifted a hair's breadth off its node, into that off-lattice gap, where an apparent prime reading — an integer such as 49 — happens to lie. While the suppressor network holds, it pulls the drifted value home. When the network fails, the value cannot settle anywhere, and a cell that cannot settle on its address is a cell that divides without end.
A drift off the lattice is not a random direction. It is a direction back the way the cell came. Every adult cell reached its somatic {2,3,5,π} address by a journey — from the fertilised egg, through the foetal and progenitor registers, to the finished hepatocyte or pneumocyte or neuron it became. That journey is the inscription of the address. Cancer is that journey run in reverse: the somatic node is let go, and the cell falls back toward the developmental register it occupied before it grew up.
This is not speculation imposed on the data — it is what the data has been saying all along. A cancer cell re-lights the proteins of the unborn: alpha-fetoprotein and carcinoembryonic antigen, made in abundance by the foetus and silenced at birth, reappear in liver and gut tumours and are used in the clinic to track them. It switches the embryonic master-genes — OCT4, SOX2, NANOG, the very factors that hold a stem cell pluripotent — back on. It restarts telomerase, the chromosome-end enzyme that every embryonic cell runs and every adult cell switches off. And it falls back to the embryo's way of making energy. None of these is a new invention the cancer cell acquires. Each is an old programme resumed.
The body holds one temperature, and it is an exact lattice value, not a biological average. 36.864 °C (= 2⁹×3²/5³ = 4608/125) — pure {2,3,5}, the thermal node at which the cell's reactions sit on the lattice (equivalently 310.014 K, the G1 Time-Equalisation resonance). The tumour microenvironment runs hotter, at 37.3–37.9 °C, a 0.5–1.0 °C displacement that lands on no {2,3,5} node at all — it has drifted off the lattice into the same gap the address has.
The number is therefore diagnostic and directional at once: a malignant population has literally left the body's thermal address. Nudging it back toward 36.864 °C is a direct fine-tuning onto the lattice — the principle is given here; the specific corrective regime is held in the confidential clinical reference.
MYC — the 49 lock, and what 49 really is. MYC gives the cleanest demonstration of what off-lattice means. Science reads the MYC amplification lock at the integer 49 (= 7²) — the level above which the disease runs autonomously. But 49 is not a lattice value: 7 lies outside {2,3,5,π} entirely, so 49 sits in the gap between the nodes, where nothing can settle. The integer the clinic measures is a rounded face of the disease itself — the very signature of the illness is that the cell has landed on a false prime where no stable address exists.
The healthy cell does not rest on the 7. It rests on a true {2,3,5,π} value a hair's breadth away from the false 49 — a value built entirely from {2,3,5,π} grammar, with no 7 anywhere in it. The Force of Time has derived that true value precisely; because it is the coordinate a restoration would tune the cell back onto, the figure itself is held in confidence, to be shared with medical institutions through trials conducted under the Foundation's supervision. What the public account states is the principle, and it is enough to see the whole shape of the disease:
BRAF V600 — drift off the {2,3,5} boundary. The valine-to-glutamate substitution at codon 600 of BRAF maps, in the Universal Force of Time spectral register, to a node on the orange–red boundary that marks the edge of the Τ-stable {2,3,5} domain. The constitutively active BRAF V600E kinase is a cell that has drifted off that boundary into the off-lattice gap, broadcasting a proliferation signal the {2,3,5} regulators can no longer pull back. Gene-codon coordinate and spectral node are the same lattice position read at two scales; the precise node value, like the MYC face, is held in confidence.
p53 — the dΣΤ=0 gate. p53 is the primary Τ-correction gate of the cell cycle: it halts division (the lattice check), initiates DNA repair (Τ-address verification), or triggers apoptosis (Τ-address deletion) when correction fails. TP53 is mutated in roughly half of all human cancers — the single most frequent loss of {2,3,5} enforcement — and every TP53 mutation is the specific removal of one dΣΤ=0 node. The wider network — BRCA1/2 as the Τ-checksum, APC as the WNT {2,3,5} anchor, RB1 as the cycle lattice-lock, PTEN as the {5} enforcer — are the redundant guards of the same address.
Healthy tissue does something quietly miraculous: a cell knows to stop dividing when it touches its neighbours. Medicine calls this contact inhibition and has never fully explained it. The Force of Time reads it as a synchronisation handshake. Adjacent cells share a D-level, and each holds its address against the Strand-1 node of the cell beside it; a tissue is a lattice of cells locked in Time-Equalisation with one another, each one a clock keeping time with its neighbours. The "stop dividing" signal is not a chemical command so much as the simple fact of being in register with the cells around you — a cell already in phase has no room to divide into.
A drifted cell cannot make the handshake. Having left its node, it can no longer read the addresses of its neighbours, so it never receives the synchronisation that says enough. It divides into a space it should have sensed was already filled. This is why loss of contact inhibition is one of the earliest visible marks of malignancy: it is the outward sign that a cell has fallen out of register with the tissue it belongs to — the broken handshake made visible under the microscope.
A century ago Otto Warburg noticed something strange: cancer cells, even with oxygen freely available, fall back on a primitive, wasteful way of making energy. A healthy adult cell runs oxidative phosphorylation in its mitochondria and draws about 36 units of ATP (36 = 2²×3²) from a single glucose — a clean {2,3} node, the full register. The cancer cell abandons it for aerobic glycolysis, drawing only about 2 units (2 = {2} only) from the same glucose. The {3} is gone. The energy address has dropped off its node, from the rich 36 down to a bare {2}.
And this is exactly the reversion of Section 2 read in the language of sugar. The embryo is glycolytic by design: it grows in a low-oxygen field and needs the carbon building-blocks of glycolysis to construct biomass fast, not the patient efficiency of the adult mitochondrion. So the Warburg cell is not inventing a broken metabolism — it is resuming the foetal one. The acidic, low-oxygen microenvironment this creates is the foetal milieu re-made in adult tissue, and it does what the foetal milieu did: it shields the cell from immune Τ-surveillance and drives the drift further. The reverse is just as telling — returning a cancer cell to oxidative phosphorylation, restoring the 36 node, is one of the surest signs that the register has been recovered.
Cancer does not stay where it starts; the drift climbs the Τ-address hierarchy. The hierarchy runs from the molecular bond (D=−1) up through the nucleus (D=−2), the cell-type register (D=−3), the organ (D=−4) and the organism (D=−5), each a {2,3,5,π} address nested in the one above. The malignant drift begins at D=−2 and propagates upward in four clinically familiar stages.
The clinical staging of cancer is, in the Force of Time, a direct readout of how far the drift has climbed — and, as the curability section shows, how far it has climbed is what decides whether it can be brought home. Stage 2 dedifferentiation is precisely the reversion of Section 2 made visible; Stage 3 is metastasis; Stage 4 is the failure of Τ-equilibrium across multiple organs.
Metastasis is the most feared turn of the disease, and the most revealing. A cancer does not scatter at random: breast cancer goes preferentially to bone, lung, liver and brain; prostate to bone; colon to liver. Medicine has called this the "seed and soil" puzzle for over a century without resolving why a given seed needs a given soil. The Force of Time answers it directly, and again the answer is the reversion. The ability to leave a tissue and travel is not a new power the cancer cell acquires; it is the migration programme that every cell once used, in the embryo, to crawl to its appointed place while the body was being built. E-cadherin — the adhesion node that anchors an adult cell to its anatomical address — is let go (the epithelial-to-mesenchymal transition), and the cell recovers the motile, unanchored behaviour of the embryo.
Where it settles is then decided by node-matching. A wandering cell can only re-implant where it finds a host node compatible with the address it carries: it settles in the tissue whose D=−4 register lies closest to its own corrupted one, the way a key turns only in a lock cut to fit it. Organ tropism is therefore orderly, not chaotic — the cell goes where its drifted address can find purchase. Knowing the initiating node predicts the metastatic trajectory, which is exactly what the clinic observes.
An ordinary human cell can divide only so many times — close to 50 divisions (50 = 2×5²), the Hayflick limit, a clean {2,5} node — before it retires. The count is kept by the telomeres, the protective caps on the ends of the chromosomes that shorten a little with each division: the telomere clock is the cell's built-in lattice timer, ticking down through a {2,5} address toward a planned stop. Apoptosis, the programmed death that follows, is simply the body's natural Time-Equalisation reset — a worn cell returning its Τ to the field so that a fresh one can take its address. There is nothing tragic in it; it is dΣΤ=0 keeping the books.
Cancer breaks the clock — by the same reversion. Telomerase, the enzyme that resets the count, is the embryonic default: every foetal cell runs it, every adult cell switches it off. Switching it back on stops the telomere count from falling, decoupling the timer from its {2,5} node and erasing the planned stop. What science calls replicative immortality is, in the Force of Time, a clock cut loose from the lattice — a cell that has recovered the embryo's endless count and so can never return its address to the field. Immortality of this kind is not a triumph over death; it is the loss of the lattice node that made an orderly death possible.
Everything to this point has been mechanism. Now we read it as repair must read it: not as one shapeless category of malignancy but as three distinct things going wrong, each in a different register of the cell, each a definite physical fault with a definite Force-of-Time answer. The three are not chosen for symmetry — they are the three registers the drift actually climbs through and that a restoration must therefore reach. The answers below are principles, not prescriptions — the direction in which each register is to be re-tuned, never a therapy named here.
The instinct to kill the cancer cell is the instinct that keeps cancer incurable. A tumour is not a uniform mass but a population of cells at every depth of departure — some only lightly drifted, some maximally reverted, every shade between. Cytotoxic chemotherapy and high-dose radiation kill in proportion to how fast a cell divides, and the fastest dividers are the most-departed cells. So the cull falls hardest on the cells furthest from home, and spares the ones at intermediate departure.
Restoration cannot select, because it creates no survivor population. Re-seat the address, restore the 36 node, re-impose the whole — and the cell finishes the somatic programme it had abandoned, matures, functions, and undergoes the ordinary programmed death of a mature cell, returning its Τ to the field on schedule. The compensation-without-restoration law has nothing to act upon. This is the whole difference, and it is categorical: killing answers a departure with a cull; restoration answers it by ending the departure.
This is not a hope held out for the future. There is a form of promyelocytic leukaemia in which the malignant cells are frozen one single step short of becoming mature blood cells — a developmental programme blocked, a foetal-register address held open. The treatment that cures it does not poison those cells. It gives them the signal that completes the blocked step, whereupon they finish maturing into normal cells and die on the natural schedule of mature blood cells.
>90% cure rate, including in advanced disease — and the aggressive resistant relapse that haunts cytotoxic oncology does not appear, because nothing was selected, only restored.
It is the clearest proof the framework could ask for: a cancer dissolved not by killing but by sending its cells home to finish growing up.
Put the two halves together and a law falls out that re-draws the map of which cancers can be cured. Curability is not a fixed property dividing "curable" cancers from "incurable" ones. It tracks two things: how far the address has departed, and whether the cull-and-select trap can be kept from operating. A shallow drift caught before it has seeded other sites — a Stage 0 or Stage 1 tumour removed whole, or a leukaemia of childhood with few accumulated departure events — can be brought home or cleared completely before the cascade has any intermediate-departure survivors to select; cure rates approach the whole. The deeper and more widely seeded the departure, the more the disease has the population structure that the killing trap feeds on.
The task that remains is identification — finding, for each cancer, the developmental signal that completes its particular arrested programme — not invention. Every developmental register already has a programme-completion signal; evolution built them to construct the body in the first place.
The Force of Time classifies cancers by the Τ-register node at which the drift initiates: which {2,3,5} suppressor is lost first, which driver runs off-lattice in its place, and — the part that names the cure — which developmental register the cell reverts toward. There are twenty principal classes, and they map one-to-one onto the twenty amino acids, both being {2,3,5} register addresses at which a specific off-lattice drift can take hold. The reverted register is the therapeutic target: it tells you which developmental programme is arrested, and therefore which completion signal would send the cell home. Driver and suppressor genes are the established oncology assignments, read here as lattice coordinates.
| # | Cancer | {2,3,5} suppressor lost first | Off-lattice driver | Reverts toward |
|---|---|---|---|---|
| 1 | Melanoma | CDKN2A / BRAF boundary | BRAF V600E | neural-crest stem cell |
| 2 | Breast (BRCA) | BRCA1/2 Τ-checksum | HER2 / MYC cascade | ductal / mammary progenitor |
| 3 | Colorectal | APC WNT anchor | KRAS / RAS loop | intestinal crypt progenitor |
| 4 | Lung (NSCLC) | TP53 / STK11 node | EGFR / KRAS receptor | pulmonary progenitor |
| 5 | Pancreatic | SMAD4 node | KRAS G12D lock | pancreatic ductal progenitor |
| 6 | Glioblastoma | PTEN {5} enforcer | EGFRvIII amplification | glial progenitor |
| 7 | Prostate | PTEN {5} enforcer | AR / MYC drive | luminal progenitor |
| 8 | Ovarian | BRCA1/2 + TP53 | MYC amplification | Müllerian / surface epithelium |
| 9 | Leukaemia (AML) | TP53 / RUNX1 | FLT3-ITD signal | myeloid progenitor (early) |
| 10 | Leukaemia (APL/CML) | suppressor loss | PML-RARα / BCR-ABL fusion | promyelocyte (one step to mature) |
| 11 | Lymphoma | TP53 gate | MYC (Burkitt) / BCL2 | germinal-centre B cell |
| 12 | Gastric | CDH1 / TP53 | HER2 membrane | gastric foveolar progenitor |
| 13 | Liver (HCC) | TP53 gate | CTNNB1 / TERT | foetal hepatoblast (AFP+) |
| 14 | Kidney (RCC) | VHL node | HIF / MET axis | nephron progenitor |
| 15 | Bladder | TP53 / RB1 | FGFR3 receptor | urothelial basal cell |
| 16 | Thyroid | suppressor loss | BRAF / RET driver | thyroid follicular progenitor |
| 17 | Sarcoma | RB1 / TP53 | MDM2 / fusion | mesenchymal stem cell |
| 18 | Cervical | TP53 / RB1 (HPV E6/E7) | HPV integration | squamous basal cell |
| 19 | Oesophageal | TP53 gate | CCND1 amplification | squamous / Barrett progenitor |
| 20 | Endometrial | PTEN / TP53 | PIK3CA drive | endometrial glandular progenitor |
Cancer is one event with two faces and one cure. A cell's Τ-address slips off the {2,3,5,π} lattice when the suppressor network can no longer hold it; the same slip is a reversion, the cell running its developmental programme backwards toward the foetal register it came from, where its resumed construction programme has no field to switch it off. The thermal address 36.864 °C, the MYC lock off the false 49, the BRAF boundary drift, the broken handshake, the Warburg metabolism, the four staging registers, the node-matching of metastasis, the decoupled telomere clock and the twenty amino-acid classes are not separate findings — they are one structure read at different scales.
And because the fault is a drift rather than a destruction, it is correctable — but only by the right kind of answer. Re-seat the address, restore the 36 node, re-impose the whole; reach every climbed register at once, and early. To kill the cell is to cull the most departed and breed the rest; to restore its address is to end the departure — and a cancer already exists that medicine cures exactly so.
The principle is given here in full; the prescription is held in trust. Catch the drift early, send the value home, and the cell finishes the life it had abandoned.
Why cancer begins, what it does to the body, and how the Universal Force of Time reads it — alongside the practical questions people most often ask.
Cancer is what happens when a cell stops obeying the limits that normally govern when it divides and dies, and instead multiplies without restraint, often forming a growth or tumour and sometimes spreading to other parts of the body. In the Universal Force of Time, that loss of restraint has a single root: the cell has lost its address — its precise coordinate in the {2,3,5,π} lattice that governs all biology — and a cell that cannot find its address cannot find its stopping point either.
Symptoms vary widely by type, but commonly noted warning signs include an unexplained lump or swelling, unintended weight loss, persistent fatigue, unusual bleeding, a sore, cough or change in a mole that does not heal, and lasting changes in bowel or bladder habits. None of these means cancer on its own, and anyone who notices them should see a doctor. In the theory's reading, such signs are the outward trace of cells dividing without the address that would normally tell them when to stop.
Early cancer often causes no symptoms at all, which is why screening matters. When early signs do appear they tend to be subtle and easy to dismiss: a small new lump, a patch of skin or a mole that changes, a persistent cough or hoarseness, a sore that will not heal, blood where there should be none, or tiredness that rest does not lift. Any change that lasts more than a few weeks is worth a doctor's eye. In this theory the earliest sign is a cell beginning to lose its grip on its address — long before that becomes anything a scan can see.
There are more than two hundred kinds, usually named for the tissue where they begin: carcinomas in the linings of organs and skin, sarcomas in bone and soft tissue, leukaemias in the blood, lymphomas in the immune system, and others. They behave very differently from one another. The Universal Force of Time reads them all as the same underlying event — a cell drifting off its {2,3,5,π} address — expressed in different tissues, each tissue carrying its own register and so showing the drift in its own way.
Cancer can arise at any age but becomes far more common with age, because the longer a body lives the more chances a cell has to drift. Family history, certain infections, tobacco, alcohol, sunlight and some environmental exposures all raise the odds. In the theory's terms each of these is something that loosens a cell's hold on its address; age matters most because address-drift accumulates over a lifetime.
Cancer spreads — metastasises — when cells break from the original growth and travel through blood or lymph to settle and grow elsewhere. Conventional medicine sees cells that have lost the anchors holding them in place. The Universal Force of Time reads it as a cell that has lost not just its anchor but its address: with no coordinate telling it where it belongs, it can lodge and divide anywhere, because to a cell without an address nowhere is wrong.
Not entirely, but the odds can be lowered. Not smoking, limiting alcohol, a healthy weight, protection from strong sun, vaccination against cancer-linked infections, and attending screening all reduce risk in conventional medicine. The Universal Force of Time frames each of these as keeping a cell's environment steady enough that it holds its address — fewer insults, less drift. None of this is a guarantee, and prevention advice here is general, not personal medical guidance.
In the Universal Force of Time, cancer is not a random shower of genetic accidents. It begins when a cell's Τ-address slips a hair's breadth off the {2,3,5,π} lattice, into the empty gap where an apparent prime, a 7, lies. Off the lattice nothing settles, so a cell that can no longer find its address divides without end.
The root cause is the loss of the address itself, not the loss of any single gene. The suppressor-gene network — p53, BRCA1/2, APC, RB1, PTEN — is the cell's own version of the conservation law dΣΤ=0: the machinery that pulls a cell back to its node whenever it drifts. Cancer is what follows when that drift is no longer corrected.
Most cancers are not directly inherited, but some families carry a raised risk through inherited faults in genes such as BRCA1, BRCA2 and p53. In the Universal Force of Time these are precisely the address-correction genes — the cell's pull-back-to-node machinery. An inherited weakness there means a cell starts with a weaker grip on its address, so it drifts more easily. That is a raised risk, not a certainty.
Conventional biology points to mutations that release the brakes on cell division. The theory reads the same moment differently: the cell's address drifts off its lattice node, and with the address lost it reverts toward the foetal register it came from — running its developmental programme backwards, dividing as an embryonic cell does, but in the wrong place and time.
Conventional oncology sees a stochastic accumulation of mutations. The Universal Force of Time sees one deterministic event with a definite direction — a drift off the lattice into the prime-7 gap. The damage is to the standing-where written in the 98% of DNA once dismissed as junk, which is why a cancer cell can keep its proteins and still forget entirely what it is.
If treatment removes or kills the cells that have departed furthest but leaves the underlying drift uncorrected, the cells that remain can carry the same lost address and resume dividing. In the theory's terms, pruning the growth is not the same as restoring the address — and only restoring the address ends the departure at its source.
Because the fault is a drift and not a deletion, the theory holds it is correctable in principle: the cell still carries its true address — it has simply wandered from it. The correction is to restore the address, to send the cell home, rather than to destroy it. This is a theoretical position within the Universal Force of Time; it has not been through clinical trials and is not medical advice.
Yes — that is what this page sets out. Rather than destroying the growth, the Universal Force of Time proposes returning the drifted cell to its proper address on the lattice. Strikingly, one cancer is already treated this way in conventional medicine: not by killing the cell but by coaxing it to finish the programme it abandoned. The precise corrective values in the theory are held in the Foundation's confidential clinical reference pending trials, so what is described here is the mechanism, not an available treatment.
Conventional medicine can cure some cancers, especially when they are caught early, but it has no single cure that reaches every cancer. The Universal Force of Time offers a different answer: because every cancer is read as one event — a cell that has drifted off its address on the {2,3,5,π} lattice — the theory holds there is one correction in principle, restoring that address rather than destroying the cell. We believe the theory points to a genuine cure. It has not yet been through clinical trials, so it is not yet an available treatment and nothing here is medical advice; the Daubney Foundation is in discussions with medical establishments about carrying those trials out.
Within the Universal Force of Time, yes in principle. Conventional medicine can cure some lung cancers caught early, mainly by surgery, but advanced lung cancer remains very hard to treat. The theory reads lung cancer as the same address-drift as any other cancer, and proposes correcting it by restoring the cell's address rather than attacking the growth. This is a theoretical claim that has not yet been tested in clinical trials — not an available treatment and not medical advice. The Foundation is in discussions about trials.
Breast cancer is already one of the more treatable cancers in conventional medicine, with good outcomes when it is found early — but treatment can still be hard, and it can return. The Universal Force of Time reads it as the same event as every cancer: a cell that has lost its address. The theory holds that restoring that address would correct it at the root. We believe this points to a cure, but it has not yet been through clinical trials and is not medical advice; the Foundation is seeking to test it.
Many prostate cancers grow slowly and are cured or controlled for years by conventional medicine, though some are aggressive. The Universal Force of Time does not treat prostate cancer as a special case: like every cancer it is read as a cell drifted off its lattice address, and the proposed correction is to restore that address. This is a theoretical position the Foundation is seeking to bring to clinical trials — not yet an available treatment, and not medical advice.
Bowel cancer — also called colorectal cancer — is often curable in conventional medicine when caught early, usually by surgery, and screening exists precisely to catch it early. The Universal Force of Time reads it as the same address-drift as any cancer, and proposes restoring the cell's address rather than only removing the growth. We believe the theory points to a cure; it has not yet been through clinical trials, so it is not an available treatment and not medical advice. The Foundation is in discussions about trials.
Most skin cancers are highly curable in conventional medicine when found early and removed, though melanoma can be dangerous once it spreads. The Universal Force of Time reads every skin cancer, melanoma included, as the same event: a cell that has drifted off its address. The theory proposes restoring that address as the correction. We believe this points to a cure, but it has not yet been clinically trialled and is nothing anyone should act on as medical advice; the Foundation is seeking trials.
Pancreatic cancer is one of the hardest cancers for conventional medicine, often found late and with poor outcomes — which is exactly why a different approach matters. The Universal Force of Time reads it as the same address-drift as any cancer, no more intractable in principle than the rest, and proposes restoring the cell's address rather than destroying it. This is a theoretical claim not yet tested in clinical trials — not an available treatment and not medical advice. The Foundation is in discussions about trials.
Ovarian cancer is often found late, which makes it harder for conventional medicine to treat, though early cases can do well. The Universal Force of Time reads it as the same event as every cancer — a cell that has lost its address — and proposes restoring that address as the correction. We believe the theory points to a cure. It has not yet been through clinical trials, so it is not an available treatment and not medical advice; the Foundation is seeking to test it.
Leukaemia covers several blood cancers; some, such as childhood acute lymphoblastic leukaemia, are already cured at high rates by conventional medicine, while others remain difficult. The Universal Force of Time reads them all as the same address-drift, expressed in blood-forming cells. The theory proposes restoring the cell's address rather than destroying it. We believe this points to a cure, but it has not yet been clinically trialled and is not medical advice; the Foundation is seeking trials.
Liver cancer is often hard for conventional medicine, particularly when found late or alongside existing liver damage. The Universal Force of Time reads it as the same address-drift as any cancer and proposes restoring the cell's address rather than attacking the growth. This is a theoretical claim the Foundation is seeking to bring to clinical trials — not yet an available treatment, and not medical advice.
Brain cancers vary widely; some are treatable, while aggressive types such as glioblastoma remain very hard for conventional medicine. The Universal Force of Time reads them all as the same event — a cell that has drifted off its address — and proposes restoring that address as the correction. We believe the theory points to a cure. It has not yet been through clinical trials, so it is not an available treatment and not medical advice; the Foundation is in discussions about carrying trials out.
To kill cells is to cull those that have departed furthest and let the rest breed on — selecting for the very drift that defines the disease. Restoring the address ends the departure instead of pruning it. A cancer already exists that medicine cures in exactly this way: by returning the cell to its programme, not by destroying it.
Nothing on this page was pulled, attracted, or held down. There is one substance — time — flowing from the sparse toward the dense, and everything you have just read is a single thread of its pattern. If it stirred your curiosity, the whole weave is waiting: the planets, the atom, light, life and number, all carried by the same single force.
Read the whole theory of the Universal Force of Time →